James Pray - Penumbra President International

PEN Stock  USD 206.15  0.45  0.22%   

President

Mr. James Pray is the President, International of Penumbra, Inc. He joined Penumbra in 2005. He has served as President, International, since 2015 and as President from 2005 to 2015. Prior to joining Penumbra, Mr. Pray had over 15 years of experience in the medical device industry, much of that in the neurovascular arena. Prior to joining Penumbra, Mr. Pray worked for Boston Scientific Corporationrationration, including as the Director of Marketing for the neurovascular division from 2000 to 2005. Mr. Pray also worked as a Research and Development Engineer and Engineering Manager for SCIMED Life Systems, a medical device company, from 1990 to 1996 since 2015.
Age 56
Tenure 9 years
Address One Penumbra Place, Alameda, CA, United States, 94502
Phone510 748 3200
Webhttps://www.penumbrainc.com
Pray received a B.S. and M.S. from the University of Minnesota.

Penumbra Management Efficiency

The company has Return on Asset of 0.0392 % which means that on every $100 spent on assets, it made $0.0392 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0835 %, implying that it generated $0.0835 on every 100 dollars invested. Penumbra's management efficiency ratios could be used to measure how well Penumbra manages its routine affairs as well as how well it operates its assets and liabilities. As of the 25th of April 2024, Return On Tangible Assets is likely to grow to 0.07. Also, Return On Capital Employed is likely to grow to 0.06. At this time, Penumbra's Asset Turnover is very stable compared to the past year.
The company has 234.34 M in debt with debt to equity (D/E) ratio of 0.23, which may show that the company is not taking advantage of profits from borrowing. Penumbra has a current ratio of 4.83, demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due. Debt can assist Penumbra until it has trouble settling it off, either with new capital or with free cash flow. So, Penumbra's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Penumbra sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Penumbra to invest in growth at high rates of return. When we think about Penumbra's use of debt, we should always consider it together with cash and equity.
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California. Penumbra operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 3800 people. Penumbra (PEN) is traded on New York Stock Exchange in USA. It is located in One Penumbra Place, Alameda, CA, United States, 94502 and employs 4,200 people. Penumbra is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Penumbra Leadership Team

Elected by the shareholders, the Penumbra's board of directors comprises two types of representatives: Penumbra inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Penumbra. The board's role is to monitor Penumbra's management team and ensure that shareholders' interests are well served. Penumbra's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Penumbra's outside directors are responsible for providing unbiased perspectives on the board's policies.
Ben Tompkins, Executive Development
Surbhi Sarna, Independent Director
Bridget ORourke, Independent Director
Adam Elsesser, Chairman of the Board, Chief Executive Officer
James Pray, President International
Robert Evans, Executive Vice President General Counsel, Secretary
Shruthi Narayan, Executive Interventional
Gita Barry, President Healthcare
Kevin Sullivan, Independent Director
Lynn Rothman, Executive Vice President, Chief Business Officer
Arani MD, CoFounder Director
Sridhar Kosaraju, President, Chief Financial Officer
Pankaj Tiwari, Executive Officer
Harpreet Grewal, Independent Director
Maggie Yuen, Chief Financial Officer
Jee HamlynHarris, Investor Officer
Don Kassing, Presiding Independent Director
Kevin Sullivanhas, Independent Director
Ben Sorci, Executive Operations
Lambert Shiu, Chief Accounting Officer
Johanna Roberts, Executive Vice President General Counsel, Secretary
Daniel Davis, President of North America
Jason Mills, Executive Strategy
Thomas Wilder, Independent Director
Walter Wang, Director
Arani Bose, Executive Director and Chief Innovator
Janet Leeds, Lead Independent Director

Penumbra Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Penumbra a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Penumbra using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Penumbra offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Penumbra's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Penumbra Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Penumbra Stock:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Penumbra. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
To learn how to invest in Penumbra Stock, please use our How to Invest in Penumbra guide.
Note that the Penumbra information on this page should be used as a complementary analysis to other Penumbra's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Complementary Tools for Penumbra Stock analysis

When running Penumbra's price analysis, check to measure Penumbra's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Penumbra is operating at the current time. Most of Penumbra's value examination focuses on studying past and present price action to predict the probability of Penumbra's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Penumbra's price. Additionally, you may evaluate how the addition of Penumbra to your portfolios can decrease your overall portfolio volatility.
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Is Penumbra's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Penumbra. If investors know Penumbra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Penumbra listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
12.519
Earnings Share
2.32
Revenue Per Share
27.565
Quarterly Revenue Growth
0.287
Return On Assets
0.0392
The market value of Penumbra is measured differently than its book value, which is the value of Penumbra that is recorded on the company's balance sheet. Investors also form their own opinion of Penumbra's value that differs from its market value or its book value, called intrinsic value, which is Penumbra's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Penumbra's market value can be influenced by many factors that don't directly affect Penumbra's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Penumbra's value and its price as these two are different measures arrived at by different means. Investors typically determine if Penumbra is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Penumbra's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.